The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building ...

Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk amid investor concerns that the Danish ...

Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline ...

Novo Nordisk (NVO) shares hit their highest level in over two months following a Financial Times report that activist hedge ...

Hedge fund aims to influence CEO appointment as drugmaker battles share price slump and competition from Eli Lilly.

Novo Nordisk (NYSE:NVO) rose to its highest level in over two months Monday after a media report said hedge fund Parvus Asset ...

The FTSE 100 and European stocks dropped and oil prices spiked on Friday, as traders react to a major escalation in tensions between Iran and Israel overnight. Israel's military s ...

Nonetheless, NVO stock has witnessed some recovery this week. Novo Nordisk gained 5% on June 10, following a report that ...

Investing.com -- Parvus Asset Management, a London-based activist hedge fund, is acquiring a stake in Danish pharmaceutical company Novo Nordisk (NYSE: NVO ), according to The Financial Times. The ...

June 9 (Reuters) - Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk (NOVOb.CO), opens new tab amid investor concerns that the Danish drugmaker has lost its first ...

Activist hedge fund Parvus Asset Management is building a stake in Ozempic -maker Novo Nordisk as the drugmaker hunts for a ...

London-based Parvus is interested in influencing the appointment of a new chief executive officer, according to the Financial Times. Have a confidential tip for our reporters? Get in Touch ...